000			01997 a2200505 4500
005			20250514235758.0
264		0	_c20051003
008			200510s 0 0 eng d
022			_a1083-4389
024	7		_a10.1111/j.1523-5378.2005.00330.x _2doi
040			_aNLM _beng _cNLM
100	1		_aBjarnason, Ingvar T
245	0	0	_aRole of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study. _h[electronic resource]
260			_bHelicobacter _cAug 2005
300			_a276-87 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAmoxicillin _xtherapeutic use
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aAnti-Ulcer Agents _xtherapeutic use
650	0	4	_aChronic Disease
650	0	4	_aClarithromycin _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHelicobacter Infections _xcomplications
650	0	4	_aHelicobacter pylori _xdrug effects
650	0	4	_aHumans
650	0	4	_aInflammation
650	0	4	_aOmeprazole _xtherapeutic use
650	0	4	_aParkinson Disease _xdrug therapy
650	0	4	_aTreatment Outcome
700	1		_aBjarnason, Inguar T
700	1		_aCharlett, André
700	1		_aDobbs, R John
700	1		_aDobbs, Sylvia M
700	1		_aIbrahim, Mohammad A A
700	1		_aKerwin, Robert W
700	1		_aMahler, Robert F
700	1		_aOxlade, Norman L
700	1		_aPeterson, Dale W
700	1		_aPlant, J Malcolm
700	1		_aPrice, Ashley B
700	1		_aWeller, Clive
773	0		_tHelicobacter _gvol. 10 _gno. 4 _gp. 276-87
856	4	0	_uhttps://doi.org/10.1111/j.1523-5378.2005.00330.x _zAvailable from publisher's website
999			_c15742357 _d15742357